Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1991-9-6
|
pubmed:abstractText |
This randomized, double-blind trial determined whether adding 90 mmol/L of alanine with a reduction in glucose to 90 mmol/L (alanine ORS) improves the efficacy of the standard oral rehydration solution (WHO-ORS). One hundred twenty-nine males aged 3-48 months with weight for length greater than or equal to 70% of NCHS, diarrheal duration less than or equal to 96 h, and clinical signs of mild to moderate dehydration were randomly allocated to either treatment group. During 0-6 h of treatment, ORS was offered at 120 ml/kg for rehydration without food or water. Beyond 6 h, ORS was offered as a volume-to-volume replacement for stool losses and a mixed diet of uniform composition was offered in amounts standardized for body weight. The most frequently isolated pathogens in alanine ORS and WHO-ORS groups were rotavirus (42 and 48%, respectively) and enterotoxigenic Escherichia coli (15 and 12%, respectively). In the 0-6 h period when food was withheld, median urine output in ml/kg (8;5, p less than 0.05) and percentage decrease in total serum solids (9:7%, p = 0.06) was significantly greater in alanine ORS than in WHO-ORS; median ORS intake and stool output were marginally lower in the alanine group but the differences were statistically not significant. Between 0 h and recovery, although the median values for duration of diarrhea (56.5 and 65.0 h), ORS consumption (260 and 323 ml/kg), and stool output (188.4 and 216.3 g/kg) were lower in the alanine ORS group, these differences with the WHO-ORS group were not statistically significant.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0277-2116
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
461-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1865280-Acute Disease,
pubmed-meshheading:1865280-Alanine,
pubmed-meshheading:1865280-Child, Preschool,
pubmed-meshheading:1865280-Cholera,
pubmed-meshheading:1865280-Diarrhea,
pubmed-meshheading:1865280-Diarrhea, Infantile,
pubmed-meshheading:1865280-Double-Blind Method,
pubmed-meshheading:1865280-Escherichia coli Infections,
pubmed-meshheading:1865280-Fluid Therapy,
pubmed-meshheading:1865280-Humans,
pubmed-meshheading:1865280-Infant,
pubmed-meshheading:1865280-Male,
pubmed-meshheading:1865280-Rehydration Solutions,
pubmed-meshheading:1865280-Rotavirus Infections
|
pubmed:year |
1991
|
pubmed:articleTitle |
Alanine-based oral rehydration solution: assessment of efficacy in acute noncholera diarrhea among children.
|
pubmed:affiliation |
Department of Pediatrics, All India Institute of Medical Sciences, New Delhi.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|